Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.61 |
| ▸ | MAPT | P10636 | 3/20 | 0.61 |
| ▸ | LMNA | P02545 | 3/20 | 0.50 |
| ▸ | SMN1; SMN2 | Q16637 | 4/20 | 0.48 |
| ▸ | NPC1 | O15118 | 3/20 | 0.48 |
| ▸ | GAA | P10253 | 2/20 | 0.48 |
| ▸ | RAB9A | P51151 | 2/20 | 0.48 |
| ▸ | KMT2A | Q03164 | 6/20 | 0.47 |
| ▸ | MEN1 | O00255 | 5/20 | 0.47 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.46 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.46 |
| ▸ | HPGD | P15428 | 1/20 | 0.46 |
| ▸ | TSHR | P16473 | 2/20 | 0.46 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28253566 | 0.87 | LMNA (0.65) | ALDH1A1MAPTLMNASMN1; SMN2NPC1 | |
| SCHEMBL28932605 | 0.87 | ALDH1A1 (0.57) | ALDH1A1MAPTLMNASMN1; SMN2NPC1 | |
| SCHEMBL10974427 | 0.84 | ALDH1A1 (0.57) | ALDH1A1MAPTLMNASMN1; SMN2NPC1 | |
| SCHEMBL29265486 | 0.83 | ALDH1A1 (0.53) | ALDH1A1MAPTLMNASMN1; SMN2NPC1 | |
| SCHEMBL2006820 | 0.83 | LMNA (0.58) | ALDH1A1MAPTLMNASMN1; SMN2NPC1 | |
| SCHEMBL2214033 | 0.81 | TSHR (0.59) | ALDH1A1MAPTLMNASMN1; SMN2NPC1 | |
| SCHEMBL17533544 | 0.80 | ALDH1A1 (0.54) | ALDH1A1MAPTLMNASMN1; SMN2NPC1 | |
| SCHEMBL5419770 | 0.80 | TSHR (0.50) | ALDH1A1MAPTLMNANPC1GAA | |
| SCHEMBL316956 | 0.79 | ALDH1A1 (0.69) | ALDH1A1MAPTLMNASMN1; SMN2NPC1 | |
| SCHEMBL9666128 | 0.79 | LMNA (0.56) | ALDH1A1MAPTLMNASMN1; SMN2NPC1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 159 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-103984214-B | Toner for developing electrostatic latent image | 柯尼卡美能达株式会社 | 2017-11-10 | — | — | CN | claimed |
| EP-0052330-B1 | NOVEL RESIN COMPOSITION, COATING MATERIAL COMPRISING SAID RESIN COMPOSITION AND METHOD FOR FORMING COATINGS | Asahi Kasei Kogyo Kabushiki Kaisha (JP) | 1984-09-05 | — | — | EP | claimed |
| US-4447580-A | POLYMER CONSISTING OF UNSATD AROMATIC AMINE AND UNSATURATED COMPOUND WITH ELECTRON ATTRACTIVE GROUP | ASAHI KASEI KOGYO KABUSHIKI KAISHA (JP) | 1984-05-08 | — | — | US | claimed |
| EP-0052330-A1 | Novel resin composition, coating material comprising said resin composition and method for forming coatings | Asahi Kasei Kogyo Kabushiki Kaisha (JP) | 1982-05-26 | — | — | EP | claimed |
| US-20260116891-A1 | Oxazepin Derivative | TEIJIN PHARMA LTD (JP) | 2026-04-30 | — | — | US | disclosed |
| EP-4512811-A1 | OXAZEPINE DERIVATIVE | Teijin Pharma Limited (JP) | 2025-02-26 | — | — | EP | disclosed |
| US-11960242-B2 | Toner | CANON KABUSHIKI KAISHA (JP) | 2024-04-16 | — | — | US | disclosed |
| CN-115576174-A | Toner and image forming apparatus | 佳能株式会社 | 2023-01-06 | — | — | CN | disclosed |
| US-20220121133-A1 | TONER | CANON KABUSHIKI KAISHA (JP) | 2022-04-21 | — | — | US | disclosed |
| US-20210101130-A1 | PARTICLE, METHOD FOR PRODUCING PARTICLE, AFFINITY PARTICLE, AND REAGENT AND KIT INCLUDING THE SAME | CANON KABUSHIKI KAISHA (JP) | 2021-04-08 | — | — | US | disclosed |
| EP-3770191-A1 | PARTICLES, METHOD FOR PRODUCING PARTICLES, AFFINITY PARTICLES, REAGENT AND KIT INCLUDING SAME, AND METHOD FOR DETECTING TARGET SUBSTANCE | CANON KABUSHIKI KAISHA (JP) | 2021-01-27 | — | — | EP | disclosed |
| US-20200363742-A1 | TONER AND TONER MANUFACTURING METHOD | CANON KABUSHIKI KAISHA (JP) | 2020-11-19 | — | — | US | disclosed |
| EP-0851307-A1 | Magnetic toner, process for producing magnetic toner, and image forming method | CANON KABUSHIKI KAISHA (JP) | 1998-07-01 | — | — | EP | disclosed |
| US-5773185-A | STYRENE MONOMER, COLOR, POLYESTER, RELEASE AGENT AND INITIATOR | CANON KABUSHIKI KAISHA (JP) | 1998-06-30 | — | — | US | disclosed |
| US-5679490-A | TONER PARTICLES COMPRISING STYRENIC POLYMER BINDER, POLYESTER POLAR RESIN, COLORANT, RELEASE AGENT; TRIBOELECTRIC CHARGING PERFORMANCE | CANON KABUSHIKI KAISHA (JP) | 1997-10-21 | — | — | US | disclosed |
| EP-0745906-A1 | Toner for developing electrostatic images, and process for producing the same | CANON KABUSHIKI KAISHA (JP) | 1996-12-04 | — | — | EP | disclosed |
| US-5149611-A | Resin composing toner having nitrogen-containing polar group or fluorine functional group; stable, non-flying, clear images | MINOLTA CAMERA KABUSHIKI KAISHA (JP) | 1992-09-22 | — | — | US | disclosed |
| EP-0052330-B1 | NOVEL RESIN COMPOSITION, COATING MATERIAL COMPRISING SAID RESIN COMPOSITION AND METHOD FOR FORMING COATINGS | Asahi Kasei Kogyo Kabushiki Kaisha (JP) | 1984-09-05 | — | — | EP | disclosed |
| US-4447580-A | POLYMER CONSISTING OF UNSATD AROMATIC AMINE AND UNSATURATED COMPOUND WITH ELECTRON ATTRACTIVE GROUP | ASAHI KASEI KOGYO KABUSHIKI KAISHA (JP) | 1984-05-08 | — | — | US | disclosed |
| EP-0052330-A1 | Novel resin composition, coating material comprising said resin composition and method for forming coatings | Asahi Kasei Kogyo Kabushiki Kaisha (JP) | 1982-05-26 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260116891-A1 | Oxazepin Derivative | HCRTR2, HCRTR1, OXTR | ALDH1A1 754/4885MAPT 4242/4885LMNA 4258/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.